0.9300
0.0000
(0.00%)
At close: January 31 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-4,343.0000
-4,343.0000
-19,335.0000
-36,148.0000
-20,034.0000
Investing Cash Flow
--
--
-47.0000
-36.0000
4,477.0000
Financing Cash Flow
6,531.0000
6,531.0000
1,178.0000
32,953.0000
38,440.0000
End Cash Position
10,868.0000
10,868.0000
8,680.0000
26,884.0000
30,115.0000
Capital Expenditure
--
--
-47.0000
-36.0000
-23.0000
Issuance of Capital Stock
6,569.0000
6,569.0000
1,196.0000
24,006.0000
37,977.0000
Issuance of Debt
--
--
--
--
437.0000
Free Cash Flow
-4,343.0000
-4,343.0000
-19,382.0000
-36,184.0000
-20,057.0000
12/31/2020 - 3/10/1993
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MBRX Moleculin Biotech, Inc.
1.5100
-1.95%
EVFM Evofem Biosciences, Inc.
0.0100
+2.04%
CSCI COSCIENS Biopharma Inc.
2.7000
-0.37%
SRZN Surrozen, Inc.
11.60
-3.89%
IVA Inventiva S.A.
2.4255
-2.00%
AJW.F AnGes, Inc.
0.2280
0.00%
HBP.TO Helix BioPharma Corp.
0.9200
0.00%
NBY NovaBay Pharmaceuticals, Inc.
0.6655
+2.38%
VVY.AS Vivoryon Therapeutics N.V.
2.0000
-0.50%
RNTX Rein Therapeutics Inc.
1.9700
-0.51%